BDRX Stock Analysis: Buy, Sell, or Hold?
BDRX - Biodexa Pharmaceuticals plc American Depositary Shs
$1.77
-0.07 (-3.80%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Get Alerted When BDRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BDRX is down 17.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BDRX is down 17.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BDRX is currently trading at $1.77, which is considered oversold relative to its 30-day fair value range of $2.02 to $2.60.
Technical Outlook: Technically, BDRX is in a strong downtrend. Immediate support is located at $1.71, while resistance sits at $2.30. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $178.30 (+9590.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BDRX is in a strong downtrend. Immediate support is located at $1.71, while resistance sits at $2.30. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $178.30 (+9590.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.02 -
$2.60
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding BDRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 9590.2% below Wall St target ($178.30)
- WARNING: Recommendation downgraded due to -17.7% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.02 -
$2.60
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.71
Resistance Level
$2.30
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-18.40
Wall Street Target
$178.30
(+9590.2%)
Revenue Growth (YoY)
-64.1%
Last updated: January 31, 2026 1:03 AM ET
Data refreshes hourly during market hours. Next update: 2:03 AM
Data refreshes hourly during market hours. Next update: 2:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDRX showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
Advanced BDRX Option Strategies
Professional options setups generated by AI based on today's BDRX price and gamma walls.
